17986220|t|Signal transduction in Alzheimer disease: p21-activated kinase signaling requires C-terminal cleavage of APP at Asp664.
17986220|a|The deficits in Alzheimer disease (AD) stem at least partly from neurotoxic beta-amyloid peptides generated from the amyloid precursor protein (APP). APP may also be cleaved intracellularly at Asp664 to yield a second neurotoxic peptide, C31. Previously, we showed that cleavage of APP at the C-terminus is required for the impairments seen in APP transgenic mice, by comparing elements of the disease in animals modeling AD, with (platelet-derived growth factor B-chain promoter-driven APP transgenic mice; PDAPP) versus without (PDAPP D664A) a functional Asp664 caspase cleavage site. However, the signaling mechanism(s) by which Asp664 contributes to these deficits remains to be elucidated. In this study, we identify a kinase protein, recently shown to bind APP at the C-terminus and to contribute to AD, whose activity is modified in PDAPP mice, but normalized in PDAPP D664A mice. Specifically, we observed a significant increase in nuclear p21-activated kinase (isoforms 1, 2, and or 3; PAK-1/2/3) activation in hippocampus of 3 month old PDAPP mice compared with non-transgenic littermates, an effect completely prevented in PDAPP D664A mice. In contrast, 13 month old PDAPP mice displayed a significant decrease in PAK-1/2/3 activity, which was once again absent in PDAPP D664A mice. Similarly, in hippocampus of early and severe AD subjects, there was a progressive and subcellular-specific reduction in active PAK-1/2/3 compared with normal controls. Interestingly, total PAK-1/2/3 protein was increased in early AD subjects, but declined in moderate AD and declined further, to significantly below that of control levels, in severe AD. These findings are compatible with previous suggestions that PAK may be involved in the pathophysiology of AD, and demonstrate that both early activation and late inactivation in the murine AD model require the cleavage of APP at Asp664.
17986220	23	40	Alzheimer disease	Disease	MESH:D000544
17986220	112	118	Asp664	ProteinMutation	tmVar:p|Allele|D|664;VariantGroup:0;OriginalGene:11820;CorrespondingGene:351;CorrespondingSpecies:10090
17986220	136	153	Alzheimer disease	Disease	MESH:D000544
17986220	155	157	AD	Disease	MESH:D000544
17986220	185	195	neurotoxic	Disease	MESH:D020258
17986220	237	262	amyloid precursor protein	Gene	11820
17986220	313	319	Asp664	ProteinMutation	tmVar:p|Allele|D|664;VariantGroup:0;OriginalGene:11820;CorrespondingGene:351;CorrespondingSpecies:10090
17986220	338	348	neurotoxic	Disease	MESH:D020258
17986220	358	361	C31	Chemical	-
17986220	479	483	mice	Species	10090
17986220	542	544	AD	Disease	MESH:D000544
17986220	552	590	platelet-derived growth factor B-chain	Gene	18591
17986220	622	626	mice	Species	10090
17986220	657	662	D664A	ProteinMutation	tmVar:p|SUB|D|664|A;HGVS:p.D664A;VariantGroup:0;OriginalGene:11820;CorrespondingGene:351;CorrespondingSpecies:10090
17986220	677	683	Asp664	ProteinMutation	tmVar:p|Allele|D|664;VariantGroup:0;OriginalGene:11820;CorrespondingGene:351;CorrespondingSpecies:10090
17986220	752	758	Asp664	ProteinMutation	tmVar:p|Allele|D|664;VariantGroup:0;OriginalGene:11820;CorrespondingGene:351;CorrespondingSpecies:10090
17986220	926	928	AD	Disease	MESH:D000544
17986220	966	970	mice	Species	10090
17986220	996	1001	D664A	ProteinMutation	tmVar:p|SUB|D|664|A;HGVS:p.D664A;VariantGroup:0;OriginalGene:11820;CorrespondingGene:351;CorrespondingSpecies:10090
17986220	1002	1006	mice	Species	10090
17986220	1115	1125	PAK-1/2/3)	Gene	18479;224105;18481
17986220	1167	1172	PDAPP	Chemical	-
17986220	1173	1177	mice	Species	10090
17986220	1260	1265	D664A	ProteinMutation	tmVar:p|SUB|D|664|A;HGVS:p.D664A;VariantGroup:0;OriginalGene:11820;CorrespondingGene:351;CorrespondingSpecies:10090
17986220	1266	1270	mice	Species	10090
17986220	1304	1308	mice	Species	10090
17986220	1345	1354	PAK-1/2/3	Gene	18479;224105;18481
17986220	1402	1407	D664A	ProteinMutation	tmVar:p|SUB|D|664|A;HGVS:p.D664A;VariantGroup:0;OriginalGene:11820;CorrespondingGene:351;CorrespondingSpecies:10090
17986220	1408	1412	mice	Species	10090
17986220	1460	1462	AD	Disease	MESH:D000544
17986220	1542	1551	PAK-1/2/3	Gene	18479;224105;18481
17986220	1604	1613	PAK-1/2/3	Gene	18479;224105;18481
17986220	1645	1647	AD	Disease	MESH:D000544
17986220	1683	1685	AD	Disease	MESH:D000544
17986220	1765	1767	AD	Disease	MESH:D000544
17986220	1876	1878	AD	Disease	MESH:D000544
17986220	1952	1958	murine	Species	10090
17986220	1959	1961	AD	Disease	MESH:D000544
17986220	1999	2005	Asp664	ProteinMutation	tmVar:p|Allele|D|664;VariantGroup:0;OriginalGene:11820;CorrespondingGene:351;CorrespondingSpecies:10090
17986220	Association	MESH:D000544	18481
17986220	Association	MESH:D000544	HGVS:p.D664A;CorrespondingGene:351
17986220	Association	MESH:D000544	CorrespondingGene:351;CorrespondingSpecies:10090;OriginalGene:11820;VariantGroup:0;tmVar:p
17986220	Association	MESH:D000544	18479
17986220	Association	MESH:D000544	224105
17986220	Association	MESH:D000544	351

